- Home
- MDRR vs HOTH Comparison
MDRR vs HOTH Comparison
Compare MDRR & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDRR
- HOTH
- Stock Information
- Founded
- MDRR 2015
- HOTH 2017
- Country
- MDRR United States
- HOTH United States
- Employees
- MDRR N/A
- HOTH N/A
- Industry
- MDRR Real Estate Investment Trusts
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- MDRR Real Estate
- HOTH Health Care
- Exchange
- MDRR Nasdaq
- HOTH Nasdaq
- Market Cap
- MDRR 15.6M
- HOTH 15.6M
- IPO Year
- MDRR 2018
- HOTH 2019
- Fundamental
- Price
- MDRR $11.30
- HOTH $1.31
- Analyst Decision
- MDRR
- HOTH Strong Buy
- Analyst Count
- MDRR 0
- HOTH 3
- Target Price
- MDRR N/A
- HOTH $4.00
- AVG Volume (30 Days)
- MDRR 640.0
- HOTH 426.2K
- Earning Date
- MDRR 08-12-2025
- HOTH 05-12-2025
- Dividend Yield
- MDRR 2.39%
- HOTH N/A
- EPS Growth
- MDRR N/A
- HOTH N/A
- EPS
- MDRR N/A
- HOTH N/A
- Revenue
- MDRR $9,485,128.00
- HOTH N/A
- Revenue This Year
- MDRR N/A
- HOTH N/A
- Revenue Next Year
- MDRR N/A
- HOTH N/A
- P/E Ratio
- MDRR N/A
- HOTH N/A
- Revenue Growth
- MDRR N/A
- HOTH N/A
- 52 Week Low
- MDRR $9.55
- HOTH $0.58
- 52 Week High
- MDRR $15.00
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- MDRR 53.75
- HOTH 51.27
- Support Level
- MDRR $10.45
- HOTH $1.21
- Resistance Level
- MDRR $11.34
- HOTH $1.41
- Average True Range (ATR)
- MDRR 0.12
- HOTH 0.10
- MACD
- MDRR 0.06
- HOTH -0.01
- Stochastic Oscillator
- MDRR 86.87
- HOTH 41.30
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged to acquire, reposition, renovate, lease, and manage income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its reportable segments were retail center properties, flex center properties, and STNL properties.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).